Assura Plc (LON:AGR – Get Free Report)’s share price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 48.45 and traded as high as GBX 48.50. Assura shares last traded at GBX 47.48, with a volume of 288,991 shares changing hands.
Analysts Set New Price Targets
Several equities research analysts have recently commented on AGR shares. Shore Capital restated a “hold” rating on shares of Assura in a report on Wednesday, October 1st. Peel Hunt restated a “buy” rating and set a GBX 60 price objective on shares of Assura in a report on Tuesday, September 30th. One equities research analyst has rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of GBX 60.
Get Our Latest Research Report on Assura
Assura Stock Performance
About Assura
Assura plc is a specialist healthcare property investor and developer. We enable better health outcomes through our portfolio of more than 600 healthcare buildings across the UK and Ireland, from which over six million patients are served.
We BUILD for health, having developed over 100 new healthcare buildings in our history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E), Healthy Communities (S), Healthy Business (G).
Assura plc achieved B Corp certification in July 2024 – the first FTSE 250 business to do so.
Featured Stories
- Five stocks we like better than Assura
- How is Compound Interest Calculated?
- The Trade Desk: After a 70% Plunge, This Could Be The Time to Buy
- What is the Nikkei 225 index?
- Tap Into 2026 AI Infrastructure Gains With This High-Growth ETF
- The 3 Best Retail Stocks to Shop for in August
- Strong Quarter, Weak Reaction: Why GitLab Shares Dropped
Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.
